QCDx sells RareScope™ instrument to UConn Health

QCDx, a private biotech company based in Farmington, CT that has developed a breakthrough Circulating Tumor Cell (CTC) liquid biopsy from a simple blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole and Ray Neag Comprehensive Cancer Center at UConn Health. The Rare Scope will be used in clinical cancer research. more